Clear Creek Financial Management’s iShares Biotechnology ETF IBB Stock Holding History

Clear Creek Financial Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,585	Closed	-$242K	–	353
2021 Q4	$242K	Buy	1,585 +20	+1%	+$3.1K	0.04%	287
2021 Q3	$253K	Sell	1,565 -568	-27%	-$95.6K	0.04%	264
2021 Q2	$349K	Buy	+2,133	New	+$329K	0.05%	215
2021 Q1	–	Sell	-2,045	Closed	-$309K	–	137
2020 Q4	$309K	Buy	+2,045	New	+$292K	0.06%	237
2020 Q3	–	Sell	-2,040	Closed	-$278K	–	163
2020 Q2	$278K	Buy	2,040 +70	+4%	+$8.92K	0.07%	187
2020 Q1	$246K	Buy	+1,970	New	+$227K	0.09%	134

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clear Creek Financial Management's IBB Position: Q1 2022 in Review

Clear Creek Financial Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,585 shares — an estimated $242K sold.

Clear Creek Financial Management first reported a position in IBB in Q1 2020 and held it in 6 quarters. The position peaked at $349K in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Clear Creek Financial Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Clear Creek Financial Management sold 1,585 iShares Biotechnology ETF shares in Q1 2022, an estimated $242K.
Clear Creek Financial Management first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 6 quarters.
Clear Creek Financial Management's iShares Biotechnology ETF position peaked at $349K in Q2 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Clear Creek Financial Management's 13F filing for Q1 2022, filed 2 May 2022.